Mondelez is a publicly traded company in the Consumer sector. This company operates across Consumer and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 4 active Congressional signals mentioning Mondelez, including 4 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
The Dietary Guidelines Reform Act of 2025 (HR2326) extends the federal dietary guideline update cycle from 5 to 10 years, providing direct regulatory relief to large packaged food and beverage manufacturers by halving mandatory reformulation frequency. The bill is early-stage (referred to subcommittee) with bipartisan cosponsors and an identical Senate companion, indicating moderate passage potential. Real market data shows consumer staples stocks have rallied 0.43% to 6.51% over the past 7 days, with $MDLZ leading at +6.51%.
→ Reduction in mandatory product reformulation frequency for cookies, crackers, and confectionery items from every 5 years to every 10 years, lowering R&D and supply chain changeover costs
HR7945, the Nitrous Oxide Safety Act of 2026, is an early-stage bill referred to the House Energy and Commerce Committee. It would ban consumer products containing nitrous oxide but carves out broad exemptions for medical/dental use, commercial food production, and food products using N2O as a propellant — meaning no impact on major food/beverage companies. The bill has only one sponsor (a junior member) and one cosponsor, with no further legislative action since introduction. Market data shows no bill-related price movements.
The PACK Act (HR6832) introduces new regulatory burdens for consumer packaged goods manufacturers by establishing strict requirements for recyclable, compostable, and reusable claims on product packaging. This bill, currently in the early stages of the legislative process, creates compliance costs for companies like Procter & Gamble, Coca-Cola, and PepsiCo. Recent market data shows mixed performance for these companies, with some experiencing gains and others declines over the past 7 and 30 days.
→ increased compliance costs for packaging claims (recyclable, compostable, reusable) and potential for deceptive claim penalties
The Childhood Diabetes Reduction Act (HR6294) mandates front-of-package health warning labels on sugar-sweetened beverages and ultra-processed foods, with labeling requirements on 5% of principal display area. Based on proven international precedent, this will cause 8-15% volume declines for targeted beverages and 4-8% for ultra-processed foods. The bill sits in early committee stage with a single Democratic sponsor and two cosponsors, presenting minimal near-term passage risk but creating a material regulatory overhang for $KO, $PEP, $MDLZ, and $KHC.
→ International precedent (Chile, Mexico) shows warning labels reduce ultra-processed snack purchases by 4-8% in the first year, with greater declines for products marketed to children.